Skip to main content
Clinical Trials/CTRI/2023/06/053380
CTRI/2023/06/053380
Not yet recruiting
未知

â??A randomized controlled trial to assess the effect of curcumin and amla containing ointment on PICC related contact dermatitis in patients receiving chemotherapy at TMH Mumbaiâ??

Pharmanza Herbal Pvt Ltd,0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: L231- Allergic contact dermatitis due toadhesivesHealth Condition 2: L235- Allergic contact dermatitis due toother chemical productsHealth Condition 3: L239- Allergic contact dermatitis, unspecified cause
Sponsor
Pharmanza Herbal Pvt Ltd,
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pharmanza Herbal Pvt Ltd,

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18\-65 years of both the sex.
  • 2\. Patient with PICC line for chemotherapy having
  • 3\. Contact dermatitis of any grade 1\- 4\.
  • 4\. Patient willing to participate and give consent.

Exclusion Criteria

  • 1\. Patient with a known history of eczema and allergy.
  • 2\. Patient on antiallergic treatment/ taking medications.
  • 3\. The patients with known liver/Renal metastasis and impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials